您的位置: 首页 > 农业专利 > 详情页

cancer treatment with dihydropyrazine pyrazines
专利权人:
LLC;SIGNAL PHARMACEUTICALS
发明人:
Heather RAYMON,Kristen Mae HEGE
申请号:
BR112015026238
公开号:
BR112015026238A2
申请日:
2014.04.16
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
Summary "Treatment of Cancer with Dihydropyrazine Pyrazines" The present invention relates to methods for treating or preventing glioblastoma multiforme (gbm) characterized by expression of the promoter o6-methylguanine-dna methyltransferase (mgmt) and / or condition, comprising: administering an effective amount of a dihydropyrazine pyrazine compound to a patient with glioblastoma multiforme (gbm) characterized by expression of o6-methylguanine-dna methyltransferase (mgmt) and / or promoter methylation status. 1/1resumo “tratamento de câncer com dihidropirazino-pirazinas” a presente invenção se refere a métodos para tratar ou prevenir glioblastoma multiforme (gbm) caracterizada por expressão da o6-metilguanina-dna metiltransferase (mgmt) e / ou estado de metilação do promotor, compreendendo a administração de uma quantidade eficaz de um composto dihidropirazino-pirazina a um paciente com glioblastoma multiforme (gbm) caracterizada por expressão da o6-metilguanina-dna metiltransferase (mgmt) e / ou estado de metilação do promotor. 1/1
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充